Get started
Author

Christopher L. D. McMillan

Observed names: Chris L.D. McMillan, Chris McMillan, Christopher L.D. McMillan, Christopher LD McMillan, Christopher McMillan, McMillan, Chris, McMillan, Christopher
ORCID: 0000-0002-5316-0986
Observed ORCID: 0000-0002-5316-0986
OpenAlex ID: A5000861370
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
2022 · Eduardo A. Albornoz, Alberto A. Amarilla, et al. · Molecular Psychiatry · 191
PDF
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
2021 · Adi Idris, Alicia Davis, et al. · Molecular Therapy · 169
PDF
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
2021 · Alberto A. Amarilla, Julian D. J. Sng, et al. · Nature Communications · 158
PDF
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
2021 · Alberto A. Amarilla, Naphak Modhiran, et al. · Frontiers in Microbiology · 61
PDF
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
2021 · Christopher L.D. McMillan, Jovin J.Y. Choo, et al. · Science Advances · 56
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2
2021 · Daniel Watterson, Danushka K Wijesundara, et al. · Clinical & Translational Immunology · 53
PDF
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2
2020 · Cecy Xi, Arianna Arianna Di Fazio, et al. · Molecules · 36
PDF
The Next Generation of Influenza Vaccines: Towards a Universal Solution
2021 · Christopher L.D. McMillan, Paul R. Young, et al. · Vaccines · 34
PDF
A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice
2021 · Jovin J. Y. Choo, Laura J. Vet, et al. · npj Vaccines · 33
PDF
Microarray patches: scratching the surface of vaccine delivery
2023 · Jovin J. Y. Choo, Christopher L. D. McMillan, et al. · Expert Review of Vaccines · 29
PDF
A platform technology for generating subunit vaccines against diverse viral pathogens
2022 · Andrew Young, Ariel Isaacs, et al. · Frontiers in Immunology · 26
Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants
2022 · Ariel Isaacs, Alberto A. Amarilla, et al. · Frontiers in Immunology · 22
PDF
A nanobody-based therapeutic targeting Nipah virus limits viral escape
2025 · Ariel Isaacs, Guillermo Valenzuela Nieto, et al. · Nature Structural & Molecular Biology · 19
Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch
2021 · Jovin J. Y. Choo, Christopher L. D. McMillan, et al. · Vaccines · 19
PDF
Elevated BMI reduces the humoral response to SARS‐CoV‐2 infection
2023 · Marcus ZW Tong, Julian DJ Sng, et al. · Clinical & Translational Immunology · 18
PDF
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
2021 · Ariel Isaacs, Zheyi Li, et al. · Vaccines · 18
PDF
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
2021 · Christopher L. D. McMillan, Stacey T. M. Cheung, et al. · npj Vaccines · 17
PDF
Basimarols A, B, and C, Highly Oxygenated Pimarane Diterpenoids from Basilicum polystachyon
2019 · Yuen P. Tan, Yongbo Xue, et al. · Journal of Natural Products · 17
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
2022 · Mahali S. Morgan, Kexin Yan, et al. · Viruses · 16
PDF
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
2022 · Christopher L.D. McMillan, Alberto A. Amarilla, et al. · Vaccine · 16
PDF
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern
2022 · Christopher L. D. McMillan, Armira Azuar, et al. · Vaccines · 15
PDF
Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
2023 · Danushka K. Wijesundara, Arthur Yeow, et al. · Molecular Therapy — Nucleic Acids · 13
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2
2020 · Daniel Watterson, Danushka Wijesundara, et al. · 13
PDF
Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types
2025 · P. Prakrithi, Laura F. Grice, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration
2022 · Camille F. de Oliveira, Walter F. F. Neto, et al. · Vaccines · 6
PDF
Works count: 47
Citation count: 1,078
H-index: 17
I10-index: 23
Year
Topic
Type